Hjem › Interstitielle lungesykdommer › Texas › Dallas
Kliniske studier for Interstitielle lungesykdommer i Dallas, TX
9 studier for Interstitielle lungesykdommer søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruttererFase 3
- Baylor University Medical Center, Dallas
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 2
- Baylor University Medical Center, Dallas
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekrutterer
- Baylor University Medical Center, Dallas
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererObservasjonsstudie
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
RekruttererObservasjonsstudie
- University of Texas Southwestern, Dallas
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RekruttererObservasjonsstudie
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekruttererFase 3
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
- University of Texas Southwestern Medical Center, Dallas
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RekruttererFase 2
- aTyr Investigative Site, Dallas
Interstitielle lungesykdommer-studier i andre byer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Charleston, SC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Ann Arbor, MI11 studier
- Aurora, CO11 studier
- Phoenix, AZ9 studier
- Salt Lake City, UT9 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Blærekreft27 studier
- Lungekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.